4D Molecular Therapeutics Inc (FDMT)
Cost of Revenue
$53.36M
TTM · Period ending: · USD
FDMT Cost of Revenue
Latest reported$53.36Mperiod ending
Latest reported$53.36Mperiod ending
FDMT Cost of Revenue ($13.57M → $53.36M)
Annual cost of revenue
High-resolution chart · PNG
FDMT cost of revenue history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 7,625,000 | |
| 141,299,000 | |
| 97,096,000 | |
| 80,253,000 | |
| 61,360,000 | |
| 53,038,000 | |
| 38,718,000 | |
| 18,362,000 | |
| 13,573,000 |